Home/Filings/4/0001628280-22-029866
4//SEC Filing

Habig Scott Michael 4

Accession 0001628280-22-029866

CIK 0001600620other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 4:31 PM ET

Size

4.4 KB

Accession

0001628280-22-029866

Insider Transaction Report

Form 4
Period: 2022-11-09
Habig Scott Michael
Chief Commercial Officer
Transactions
  • Purchase

    Common Stock

    2022-11-09$5.01/sh+5,000$25,0755,000 total

Issuer

Aurinia Pharmaceuticals Inc.

CIK 0001600620

Entity typeother

Related Parties

1
  • filerCIK 0001938159

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:31 PM ET
Size
4.4 KB